Progressive Care (RXMD) 2019 Annual Report Earnings Call and Business Update with Shital Mars, CEO. Ms. Mars called SmallCapVoice.com, Inc. in to discuss the posted record-breaking data, which was defined by sequential quarterly improvement throughout the year in all major financial performance metrics, including EBITDA profitability in Q4 2019. In addition, the Company is pleased to report that this momentum has continued to define results so far in 2020, as the Company sees market share gains based on its established leadership position in-home delivery and disease prevention protocols which have become a critical competitive advantage due to concerns over the spread of Coronavirus Disease 2019 (“COVID-19”).

S. Parikh Mars, CEO of Progressive Care, commented, “2019 was an extraordinary year for Progressive Care. We confronted difficult challenges and put together the most impressive stretch of performance in our history in response. Each quarter – each month – was better than the last and now defines a fresh context for 2020.”

Key 2019 Annual Report Highlights

Consolidated monthly gross sales across all locations for 2019 totaled $32.6 million, representing year-over-year growth of 58% compared to the twelve months ended 12/31/2018,

Total Gross Profit across all locations for 2019 totaled $7.97 million, representing year-over-year growth of 70% compared to the twelve months ended 12/31/2018,

EBITDA for Q4 2019 turned positive, at $300,904,

2019 was characterized by four consecutive quarters of declining overall net losses.

Management believes that Progressive Care is now leveraging a strong competitive advantage in its core pharmacy segment due to the COVID-19 crisis. The prescription drug prescriber community has quantifiable financial incentives driven and defined by the risk of patient infection rates. This is even more acute in the geographic area defining the Company’s primary operational footprint (Florida), where demographic variables confer a greater risk in COVID-19 patient outcomes due to age-related factors.

Progressive Care was the first mover in the space in terms of home delivery and disease prevention and management. Competitors in the space are behind the curve. The Company believes risk-based financial incentives at the clinic and prescriber level are actively translating into market share growth that should show up in Q1 and Q2 2020 financial data.

Mars continued, “It is paramount that our shareholders know we are uniquely well-positioned to thrive in the current tragic COVID-19 environment. We have been doing home delivery for 13 years and used our expertise in infectious disease to become one of the first to implement contactless protocols for the safety of our patients and staff. Our competitors are trying to cobble something together on the fly. At our pharmacies, free same-day and next day delivery are standard, remote health monitoring is standard, adherence coaching is standard, safe delivery is standard. We lead the way in best practices as more and more pharmacies look to adopt some form of our model in the short run. This is our bread and butter, and we already see very clear evidence of market share gains based on liability consideration in the prescriber channel as a result.”

SmallCapVoice.com podcast interview with Alexander Salgado, CEO and co-founder of Veritas Farms (VFRM).

Alexander Salgado, CEO and co-founder of Veritas Farms called in to SmallCapvoice.com, Inc. to go over the business model and markets for the Company. In addition, Salgado outlined the milestones for the Company in 2019 and Highlighted the goals for the Company in 2020. So far in 2020, VFRM has been prolific with their news flow and efforts. Recently, VFRM announced the expansion of their award winning Veritas Pet line by adding three separate ingestible products designed specifically for pets, which are all made with natural ingredients and infused with the Company’s full spectrum hemp oil.

Veritas Farms, Inc. (VFRM) is a vertically integrated agribusiness focused on producing superior quality, whole plant, full spectrum hemp oils and extracts containing naturally occurring cannabinoids. The Company currently owns and operates a 140-acre farm and production facilities in Pueblo, Colorado, and is registered with the Colorado Department of Agriculture to grow industrial hemp. The Company markets and sells products under its Veritas Farms™ brand and manufactures private label products for a number of leading distributors and retailers.

Veritas Farms™ brand full spectrum hemp oil products include vegan capsules, tinctures, formulations for sublingual applications and infused edibles, lotions, salves, and oral syringes in a variety of size formats and flavors. All Veritas Farms™ brand products are third-party laboratory tested for strength and purity. The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at www.sec.gov.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $3,500 from a third party on behalf of the issuer on 3-5-2020 for 30 days of service. SmallCapVoice.com, Inc. received $3,500 from a third party on behalf of the issuer on 3-5-2020 for 30 days of service.

Revenue from continuing operations increased 39% versus 2018. Company expands operations to include pharmaceutical manufacturing.

Revenue from continuing operations increased 39% versus 2018.

Company expands operations to include pharmaceutical manufacturing.

IRVINE, CA / ACCESSWIRE / March 13, 2020 / Terra Tech Corp. (OTCQX:TRTC) (“Terra Tech” or the “Company”) today announced its financial results for the year ended December 31, 2019.

Matt Morgan, Chief Executive Officer of Terra Tech, commented, “In 2019, the cannabis market experienced significant challenges as market volatility impacted operators’ ability to access capital and regulatory constraints continued to restrict growth in the industry. During this time, Terra Tech continued to grow brand recognition of its medical and adult-use cannabis products, while also executing on its transformative strategy of merging with OneQor Pharmaceutical (“OneQor”) which closed in early 2020. Following this transaction, the Company now has a new business model that positions us as an acquirer, owner and manager of a diverse group of businesses operating within the cannabinoid industry. These businesses will be niche market leaders that operate in attractive markets with defensible market positions and clear pathways to profitability. This new structure enables the Company to flexibly and opportunistically divest underperforming assets and reallocate capital toward opportunities in the cannabinoid market. Our 2020 goals are focused around leveraging OneQor’s team of world-class scientists to create proprietary formulations and manufacture cannabinoid products for the pharmaceutical industry, as well as to revitalize the THC-related assets operated by Terra Tech. We plan to fund these initiatives utilizing capital from asset sales. We expect this strategy, together with our plans to streamline our cost structure, to increase the value of the Company.”

Financial Update

* For the year ended December 31, 2019, the Company generated revenues from continuing operations of approximately $28.05 million, compared to approximately $20.16 million for the year ended December 31, 2018, an increase of approximately $7.89 million. The increase was primarily due to ramping up production operations, a $3.32 million impact, and increasing dispensary revenue, which accounted for $3.71 million. The Company also saw a 20% increase in revenue generated by Edible Garden from the sales of its produce and herb products.

* Under GAAP standards, the Company was not permitted to record the top line revenue for the discontinued operations. During the course of the quarter, the Company has been operating the discontinued operations and will continue to operate them until the State of Nevada approves the transfer of the cannabis permits. The actual annual revenue including the discontinued operations was $38.56 million, compared to $31.33 million for the year ended December 31, 2018, an increase of $7.23 million or 23%.

* Terra Tech’s gross profit for the year ended December 31, 2019 was approximately $14.65 million, compared to a gross profit of approximately $7.01 million for the year ended December 31, 2018, an increase of approximately $7.64 million. Gross margin for the year ended December 31, 2019 was approximately 52.23%, compared to approximately 34.77% for the year ended December 31, 2018.

* Selling, general and administrative expenses for the year ended December 31, 2019 were approximately $45.32 million, compared to approximately $37.91 million for the year ended December 31, 2018, an increase of approximately $7.41 million.

* The net loss attributable to Terra Tech for the twelve months ending December 31, 2019 was $46.93 million, or $0.44 per share, compared to a net loss of $39.75 million, or $0.56 per share, for the twelve months ending December 31, 2018.

* The Company had $1.

VFRM will continue with the expansion and distribution of Hooters Spirits products into off-premise retail locations.

Richard DeCicco, chief executive officer of Iconic Brands, Inc. (OTCQB:ICNB) (“Iconic” or the “Company”) called back in to SmallCapvoice.com (“SCV”), Inc. to go over the recent news and upcoming events for the Company. DeCicco gave SCV the exclusive scoop on a high profile meet a greet making this interview a must listen. In the interview DeCicco discussed how the relationship and roll-out with the private-label Hooters Spirits products, a premium line of alcohol beverages that includes an array of vodka, gin, rum, tequila and whiskey options. In February VFRM announced that line is now available in Hooters corporate restaurants in 22 states across the United States. VFRM will continue with the expansion and distribution of Hooters Spirits products into off-premise retail locations.

Relationship building is key to Iconic Brands, Inc. And clearly something they excel at. They have had huge success with Christie Brinkley and their Bellissima line of Prosecco and Sparkling Wines. Back in December 2019, with the help of Christie Brinkley, ICNB sold nearly 30,000 bottles of Bellissima with 25 minutes of air time on QVC. In addition, shortly after meeting NASCARs most popular driver, Chase Elliott, Elliot came on board signing multi-year deal as a brand ambassador for its premium line of Hooters Spirits that includes personal appearances at select Hooters Spirits events.

Iconic Brands, Inc. is a lifestyle branding company with the highest expertise of developing, from inception to completion, alcohol beverages for itself and third parties. Iconic markets and places products into national distribution through long-standing industry relationships. Iconic is a leader in “celebrity branding” of beverages, procuring superior and unique products from around the world and branding its products with internationally recognized celebrities. It currently offers Bellissima Prosecco and BiVi Vodka. In addition, Iconic developed the Hooters Spirits line of premium spirits in partnership with United Spirits, Inc., a leading private-label beverage company and affiliate of Iconic, for Hooters restaurants and off-premise retail locations both domestically and internationally.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $6,500 from a third party on behalf of the issuer on 1-13-2020 for 30 days of Audio Interview service. SmallCapVoice.com, Inc. received $750 from the company on 3-10-20 for 30 days of Audio Interview service.

ISWH is an emerging diversified leader in the health and wellness space.

Alonzo Pierce, President of International Spirits & Wellness Holdings, Inc. (OTC: ISWH) (“ISWH” or the “Company”), an emerging diversified leader in the health and wellness space, called in to SmallCapVoice.com to go over the business model and the markets his Company operates in. In addition, he discussed the upcoming corporate name to ISW Holdings, Inc., the Company plans to up-list its shares onto the OTCQB exchange, his Company’s work in the home healthcare market that currently services several major cities in Texas, including Houston, San Antonio, and El Paso. ISWH has now begun the process of establishing home healthcare operations in Nevada (Las Vegas and Reno), New Mexico (Santa Fe), Arizona (Phoenix), and Florida (The Villages). He delivers his personal message of gratitude and encouragement to his shareholders making this interview a must listen.

ISWH is a global brand management holdings company with diverse operational interests, including commercial-stage operations in the spirits, CBD, and home healthcare markets, and development-stage operations in the logistics and supply chain and renewable energy markets.

Based in Nevada, the Company’s expertise lies in the strategic development and aggressive early growth of its brands and the establishment of these brands as viable and profitable as an incubator. ISWH nurtures emerging brands through critical stages of market development, including conceptualization, go-to-market strategy, supply chain and logistics engineering, integrated marketing, and distribution. ISWH is creating and managing brands across a spectrum of disruptive industries. The Company has now established itself as a health and wellness leader with a focus on reshaping the CBD products and home healthcare markets through state-of-the-art technology and execution. The company has also partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace with VOLUM.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $875 from the company on 3-11-20 for 30 days of Audio Interview service.

NGTF held its quarterly investor call on Tuesday, March 3, 2020 at 4:30 PM Eastern. Nightfood CEO Sean Folkson answered questions concerning the Company submitted prior to the call.